Evangelos Tsiambas

1.4k total citations
103 papers, 977 citations indexed

About

Evangelos Tsiambas is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Evangelos Tsiambas has authored 103 papers receiving a total of 977 indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Oncology, 39 papers in Molecular Biology and 21 papers in Cancer Research. Recurrent topics in Evangelos Tsiambas's work include Cancer-related Molecular Pathways (16 papers), HER2/EGFR in Cancer Research (12 papers) and RNA modifications and cancer (11 papers). Evangelos Tsiambas is often cited by papers focused on Cancer-related Molecular Pathways (16 papers), HER2/EGFR in Cancer Research (12 papers) and RNA modifications and cancer (11 papers). Evangelos Tsiambas collaborates with scholars based in Greece, United Kingdom and Switzerland. Evangelos Tsiambas's co-authors include Vasileios Ragos, Nicholas Mastronikolis, Aristeidis Chrysovergis, Nikolaos S. Salemis, Vasileios Papanikolaou, Dimitrios Peschos, Stavros Gourgiotis, Stylianos Mastronikolis, Efstratios Patsouris and Leonardo Solaini and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gene.

In The Last Decade

Evangelos Tsiambas

95 papers receiving 966 citations

Peers

Evangelos Tsiambas
Evangelos Tsiambas
Citations per year, relative to Evangelos Tsiambas Evangelos Tsiambas (= 1×) peers Chun-Hung Hua

Countries citing papers authored by Evangelos Tsiambas

Since Specialization
Citations

This map shows the geographic impact of Evangelos Tsiambas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evangelos Tsiambas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evangelos Tsiambas more than expected).

Fields of papers citing papers by Evangelos Tsiambas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Evangelos Tsiambas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evangelos Tsiambas. The network helps show where Evangelos Tsiambas may publish in the future.

Co-authorship network of co-authors of Evangelos Tsiambas

This figure shows the co-authorship network connecting the top 25 collaborators of Evangelos Tsiambas. A scholar is included among the top collaborators of Evangelos Tsiambas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Evangelos Tsiambas. Evangelos Tsiambas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chrysovergis, Aristeidis, Vasileios Papanikolaou, Evangelos Tsiambas, et al.. (2025). Impact of C-FOS/C-JUN Transcriptional Factors Co-Expression in Non–small Cell Lung Carcinoma. Cancer Diagnosis & Prognosis. 5(1). 15–20.
2.
Chrysovergis, Aristeidis, Panagiotis Stathopoulos, Evangelos Tsiambas, et al.. (2024). Clinical Impact of C-myc Oncogenic Diversity on Solid and Lymphoid Malignancies. MAEDICA – a Journal of Clinical Medicine. 19(2). 355–359. 1 indexed citations
3.
Derka, Spyridoula, et al.. (2024). Pleomorphic Adenoma of Minor Salivary Glands: a Rare Case Report. MAEDICA – a Journal of Clinical Medicine. 19(2). 434–438. 1 indexed citations
4.
Tsiambas, Evangelos, et al.. (2023). Mathematical modeling for Delta and Omicron variant of SARS-CoV-2 transmission dynamics in Greece. Infectious Disease Modelling. 8(3). 794–805. 2 indexed citations
5.
Tsiambas, Evangelos, Sotirios Maipas, Irene Thymara, et al.. (2023). Impact of CD34-dependent Micro Vessel Density on Periapical Odontogenic Cysts. Cancer Diagnosis & Prognosis. 3(2). 189–193. 3 indexed citations
6.
Papanikolaou, Vasileios, Aristeidis Chrysovergis, Vasileios Ragos, et al.. (2023). Impact of Amplified Oncogenes on Salivary Gland Carcinomas. Cancer Diagnosis & Prognosis. 3(5). 528–532. 1 indexed citations
7.
Tsiambas, Evangelos, et al.. (2023). P53/MDM2 Complex-Based Targeted Strategies in Colon Adenocarcinoma. Acta Medica Academica. 52(1). 24–29. 3 indexed citations
8.
Mastronikolis, Stylianos, Evangelos Tsiambas, Οlga E. Makri, et al.. (2022). c-FOS Expression Analysis in Pterygia Cell Spot Arrays. In Vivo. 36(5). 2143–2148. 1 indexed citations
9.
Kouzoupis, Anastasios V., Evangelos Tsiambas, George Tsouvelas, et al.. (2022). P53 Suppressor Gene Tissue Microarray-based Protein Expression Analysis in Meningiomas. In Vivo. 36(5). 2205–2210. 1 indexed citations
10.
Chrysovergis, Aristeidis, Nicholas Mastronikolis, Evangelos Tsiambas, et al.. (2022). Impact of Ubiquitination Signaling Pathway Modifications on Oral Carcinoma. Cancer Diagnosis & Prognosis. 2(1). 1–6. 4 indexed citations
11.
Papanikolaou, Vasileios, Aristeidis Chrysovergis, Stylianos Mastronikolis, et al.. (2021). Impact of K-Ras Over-expression in Laryngeal Squamous Cell Carcinoma. In Vivo. 35(3). 1611–1615. 7 indexed citations
12.
Kyrodimos, Efthymios, Aristeidis Chrysovergis, Nicholas Mastronikolis, et al.. (2020). Impact of Chromosome 9 Numerical Imbalances in Oral Squamous Cell Carcinoma: A Pilot Grid-Based Centromere Analysis. Diagnostics. 10(7). 501–501. 2 indexed citations
13.
Papanikolaou, Vasileios, Aristeidis Chrysovergis, Nicholas Mastronikolis, et al.. (2020). Topoisomerase IIa Protein Expression Patterns in Laryngeal Squamous Cell Carcinoma. Anticancer Research. 40(2). 807–811. 3 indexed citations
14.
Giannakopoulos, Xenofon, Hercules Sakkas, Vasileios Ragos, et al.. (2019). Impact of enterococcal urinary tract infections in immunocompromised - neoplastic patients.. PubMed. 24(5). 1768–1775. 19 indexed citations
15.
Tsiambas, Evangelos, et al.. (2019). HER2/Topoisomerase IIa co-amplified breast adenocarcinoma "mirror" cases with different Topoisomerase IIa expression patterns.. PubMed. 22(2). 555–556. 1 indexed citations
16.
Tsiambas, Evangelos, et al.. (2019). Epstein-Barr Virus MicroRNAs in Nasopharyngeal Carcinoma. Pathology & Oncology Research. 26(2). 1347–1348. 1 indexed citations
17.
Mastronikolis, Nicholas, Evangelos Tsiambas, Andreas Karameris, et al.. (2018). Numerical Imbalances of Chromosome 7 in Oral Squamous Cell Carcinoma. Anticancer Research. 38(4). 2339–2342. 3 indexed citations
18.
Tsiambas, Evangelos, Nicholas Mastronikolis, Stavros N Georgiannos, et al.. (2017). Chromosome 7 Multiplication in EGFR-positive Lung Carcinomas Based on Tissue Microarray Analysis. In Vivo. 31(4). 641–648. 9 indexed citations
19.
Tsiambas, Evangelos, Dimitrios Tsounis, Andreas Karameris, et al.. (2009). Chromogenic In Situ Hybridization Analysis of Epidermal Growth Factor Receptor Gene/Chromosome 7 Numerical Aberrations in Hepatocellular Carcinoma Based on Tissue Microarrays. Pathology & Oncology Research. 15(3). 511–520. 8 indexed citations
20.
Tsiambas, Evangelos, et al.. (2006). HER2/neu expression and gene alterations in pancreatic ductal adenocarcinoma: a comparative immunohistochemistry and chromogenic in situ hybridization study based on tissue microarrays and computerized image analysis.. PubMed. 7(3). 283–94. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026